Debtech is a legal intelligence platform that aims to become a global automation portal for every type of finance agreement - from simple mortgages to billion-dollar corporate loans. Debtech has a two-tiered format for its business. Its Tier 1 'Platform' connects finance stakeholders - from lenders and lawyers to CFOs and borrowers - on one single platform so that everyone is in one place for the lifecycle of the agreement. Its Tier 2 'Marketplace' is an 'App Store' of simple, plug-and-play apps where one app automates one manual workflow. The company asserts that the global legal intelligence market would touch £29.5 billion by value in 2026. Debtech cites that its portal allows finance organisations to achieve time savings of over 90% and cost savings of up to 50x compared to conventional offline platforms. The company seeks to raise £150,000 (SEIS) of equity funding to upgrade the platform's infrastructure for Most Valuable Product (MVP) Version 1 within 90-days to create MVP V2, onboard its six early corporate customers for paid trials on MVP v2, and build five core apps.
days to go:
Expired
investment:
£159,512
OnCare app (iOS and Android) for care workers: enables care workers to report on their client visits through their smartphone, instead of having to deal with large amounts of paperwork.
days to go:
Expired
investment:
£149,470
Buzzhire uses mobile technology to provide employers with temporary staff. Buzzhire's platform allow clients to book staff with as little as 3 hours notice. As a employer, you are able to see previous reviews of temporary workers.
days to go:
Expired
investment:
£54,486
Thyngs are connecting real world experiences to people's digital mobile lives so any marketer can transform their existing promotional objects into interactable encounters. Thyngs has already developed ground-breaking services in events, entertainment and the charitable sectors since being founded in March 2016.
days to go:
Expired
investment:
£50,000
Mous is a fashion/tech brand that’s disrupting the $37billion phone accessories category. Mous has had huge exposure already for their latest ergonomic and slim iPhone 6 case that holds and retracts headphones, solving very real shopper problems. The trends of wireless earphones present a real opportunity for Mous in the future.
days to go:
Expired
investment:
£41,580
Lenderwize is the first lending platform for Telecom Operators, offering investment opportunities in a new Asset Class. Its typical clients are mid-sized operators with an annual revenue of 50-300 million USD. Lenderwize sells to large Tier1 Operators (Originators) and buys from smaller (Terminating) Operators. Thanks to Lenderwize's in-depth industry knowledge, they have identified 1350 wholesalers in need of $96 million, making the Cost of Acquisition of clients very low. Additionally, its lean Back Office, Credit Vetting and Loan Management gives Lenderwize a competitive edge over Market Invoice or Funding Circle. With the funds, the company will invest in technology development and integration, increasing sales, marketing activities, and recruitment to enhance its reach globally.
days to go:
Expired
investment:
£100,045
Africa New Energies has a mission to improve the lives of millions of sub-Saharan Africans by delivering them electricity in an environmentally responsible way. The company is an innovative oil and gas exploration business. We start with a huge asset: a drilling concession in Namibia in territory the size of Wales which contains 32 potential natural gas and oil fields. A conservative estimate is that there are 1.6 billion barrels of oil in the rocks there. If we can prove that the energy is there and can be economically accessed we will have increased our value 600 fold and be sitting on blocks valued at $6.5bn/£4bn.
days to go:
Expired
investment:
£563,631
Invisage is a cloud-based platform that helps asset managers optimise their performance and research costs by identifying the true value of investment research. The company asserts that Directive 2014/65/EU has led to the investment research market falling from $16.5 billion to $14 billion as managers look to reduce costs and increase value. Invisage asserts that its platform helps asset managers identify, objectively measure ‘value’ added by research, and consume only high-impact research. The company also offers a web-based research consolidation, valuation and attribution solution that gives a quantitative assessment of value added by research to client portfolios. Invisage will use the investment to enhance deep learning-based Natural Language Processing (NLP) models that detect the implicit ideas from research narrative, build partnerships with data providers and other solution providers, and market scale its sales function
days to go:
Expired
investment:
£75,000
Coinrule is a smart assistant designed for millennials looking to automate their investments in cryptocurrencies, financial assets and build trading strategies without having to program a single line of code. The platform empowers regular traders and investors to compete with professional algorithmic traders and hedge funds. Users can pick 'building blocks' via a simple interface to create trading strategies which also get backtested on historical data. The company aims to make trading an accessible option for all. They have received awards such as MKB Fintech Lab - Cohort 2018, Pioneer 500, and Alpha Startup at Web Summit 2018. Their exit strategy would be a sale to a larger player either in the crypto space (i.e. Binance/Coinbase) or in the traditional brokerage space (i.e. IG Index, Fidelity).
days to go:
Expired
investment:
£160,000
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
